Loading clinical trials...
Loading clinical trials...
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Conditions
Interventions
HP802-247
Placebo (Vehicle)
Locations
30
United States
University of AZ College of Medicine
Tucson, Arizona, United States
Center for Clinical Research
Castro Valley, California, United States
ILD Consulting, Inc.
Encinitas, California, United States
Vascular Surgery Associates
Los Angeles, California, United States
UCSD Wound Treatment and Research Center
San Diego, California, United States
University of Miami
Miami, Florida, United States
Start Date
February 1, 2009
Primary Completion Date
April 1, 2011
Completion Date
July 1, 2011
Last Updated
October 24, 2016
NCT06811909
NCT05489588
NCT06606210
NCT06544564
NCT05549609
NCT04737941
Lead Sponsor
Healthpoint
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions